Implanet announced initial positive results following use of the Jazz Lock® spinal implant in >25 cases. Full global launch is slated to occur by the end of 2016.
Lattice Biologics closed a private placement for gross proceeds of up to US $0.75MM to fund M&A and the acquisition of donors to support production of an amniotic fluid product for regenerative use. The novel regenerative therapeutic will target osteoarthritis, spine, sports-medicine, foot/ankle and other indications.Â
Vertebral Technologies entered into a strategic partnership with BioMedical Technologies International to distribute InterFuse S™ and T™ spinal fusion devices throughout Mexico.